Genovis delivered a Q1 report broadly in line with our estimates, meeting our sales projections showing 17% organic growth and EBITDA approximately 3% below our SEK9.8m projection, this despite cSEK4m in FX-headwinds during the quarter. We expect minor estimate revisions and anticipate a positive share price reaction at open.
LÄS MER
